Arabic Arabic English English French French German German
dark

Pfizer to pay $2.26B for cancer treatment developer Trillium

Pfizer is spending more than $2 billion in cash to buy a drugmaker focused on cancer treatments. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Hospitals often outsource important services to companies that prioritize profit over patients

Next Post

Al-Qassim: 500,000+ Beneficiaries of «Taakkad» Centers to Date

Related Posts
Total
0
Share